Fluidigm Corp. | Balance Sheet

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
84,344.00
115,301.00
94,972.00
59,430.00
63,136.00
95,401
Total Accounts Receivable
10,552.00
22,384.00
25,457.00
14,610.00
15,049.00
16,651
Inventories
8,148.00
15,991.00
17,924.00
20,114.00
15,088.00
13,003
Other Current Assets
1,540.00
2,221.00
5,742.00
2,517.00
1,528.00
2,051
Total Current Assets
104,584.00
155,897.00
144,095.00
96,671.00
94,801.00
127,106
Net Property, Plant & Equipment
6,818.00
13,889.00
15,258.00
16,525.00
12,301.00
8,825
Total Investments and Advances
1,942.00
27,499.00
6,493.00
-
-
-
Intangible Assets
1,300.00
206,308.00
203,002.00
190,599.00
178,261.00
165,921
Other Assets
2,271.00
3,966.00
1,202.00
2,600.00
1,988.00
1,795
Total Assets
116,915.00
407,559.00
370,050.00
306,395.00
287,351.00
303,647
Accounts Payable
4,353.00
5,919.00
6,094.00
3,967.00
4,211.00
Other Current Liabilities
13,598.00
23,466.00
23,987.00
25,533.00
29,263.00
Total Current Liabilities
17,951.00
29,385.00
30,081.00
29,500.00
33,474.00
Long-Term Debt
-
195,455.00
194,673.00
194,951.00
195,238.00
Deferred Taxes
-
26,152.00
23,595.00
21,140.00
16,919.00
Other Liabilities
2,550.00
6,148.00
6,800.00
7,571.00
10,785.00
Total Liabilities
20,501.00
257,140.00
255,149.00
253,162.00
256,416.00
Common Equity (Total)
96,414.00
150,419.00
114,901.00
53,233.00
30,935.00
Total Shareholders' Equity
96,414.00
150,419.00
114,901.00
53,233.00
30,935.00
Total Equity
96,414.00
150,419.00
114,901.00
53,233.00
30,935.00
Liabilities & Shareholders' Equity
116,915.00
407,559.00
370,050.00
306,395.00
287,351.00

About Fluidigm

View Profile
Address
7000 Shoreline Court
South San Francisco California 94080
United States
Employees -
Website http://www.fluidigm.com
Updated 07/08/2019
Fluidigm Corp. engages in the manufacture and marketing of innovative technologies and tools for life sciences research. It sells instruments and consumables, including integrated fluidic circuits; assays and reagents to academic institutions; clinical research laboratories, and biopharmaceutical; agricultural biotechnology; and companies and contract research organizations. The company was founded by Stephen R.